旧和新系统性治疗中度至重度亚托邦性皮肤炎的比较
Hyun J Yim1, Tiffany Jean2, Peck Y Ong3
1Department of Internal Medicine, Kaiser Los Angeles Medical Center, Los Angeles, CA, USA.
Current allergy and asthma reports
|April 17, 2024
概括
与传统免疫抑制剂相比,较新的全身治疗方法,如生物药物和JAK抑制剂,在亚托皮炎 (AD) 中提供了更好的疗效和安全性. 治疗个性化是有效管理AD的关键.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对阿托皮性皮炎 (AD) 的传统全身治疗包括皮质类固醇和疾病修饰性抗性药物 (DMARDs).
- 这些常规疗法提供了症状缓解,但与显著的长期不良影响有关.
- 最近的进展引入了新的全身性药物,其安全性和疗效配置文件得到了改进.
研究的目的:
- 审查和比较传统的系统性治疗阿托皮性皮肤炎 (AD).
- 讨论和评估阿尔茨海默病的新系统治疗方案.
- 提供当前和新兴治疗中度至重度AD的概述.
主要方法:
- 对亚托皮性皮肤炎全身治疗的文献综述.
- 传统和新型AD疗法的疗效和安全数据的比较.
- 对临床试验结果和元分析的分析.
主要成果:
- 较新的药物如dupilumab,tralokinumab,lebrikizumab和口服JAK抑制剂在AD治疗中显示出显著的疗效和安全性.
- 高剂量的环素和杜皮卢马布显示出比甲状腺素和阿扎西奥普林更大的有效性.
- 高剂量的上西替尼是高度有效的,但与更多的不良事件相关;针对性的生物药物越来越多地优先于传统的免疫抑制剂.
结论:
- 有针对性的生物治疗正在成为AD的首选方法,而不是传统的免疫抑制剂.
- 考虑功效,副作用,机制和管理的个性化治疗策略对于最佳的AD管理至关重要.
- 目前正在进行的研究继续扩大阿尔茨海默病的治疗领域.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
240
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
240
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Antiasthma Drugs: Leukotriene Modifiers
282
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
282


